NSDHL Activators
NSDHL Activators are a group of chemicals that indirectly enhance the functional activity of NSDHL by primarily inhibiting the activity of the enzyme HMG-CoA reductase, a key player in the cholesterol biosynthesis pathway. By inhibiting HMG-CoA reductase, these compounds, which include Lovastatin, Simvastatin, Pravastatin, Atorvastatin, Fluvastatin, Pitavastatin, Cerivastatin, Mevastatin, and Compactin, increase the demand for cholesterol biosynthesis. This increased demand for cholesterol biosynthesis can lead to an increased functional activity of NSDHL, as NSDHL is an enzyme that plays a crucial role in the biosynthesis of cholesterol.
Furthermore, other NSDHL Activators such as Zaragozic Acid A exert their effects by inhibiting squalene synthase, another enzyme involved in cholesterol biosynthesis. Similar to the mechanism of HMG-CoA reductase inhibitors, the inhibition of squalene synthase by these compounds can indirectly increase the demand for NSDHL activity. This increased demand for NSDHL activity due to the inhibition of squalene synthase can lead to an increased functional activity of NSDHL in the cholesterol biosynthesis pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, a key enzyme in the cholesterol biosynthesis pathway. This can indirectly enhance NSDHL activity by increasing the demand for cholesterol biosynthesis. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin also inhibits HMG-CoA reductase, and thereby can indirectly enhance NSDHL activity via the same mechanism as Lovastatin. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $69.00 $162.00 $787.00 | 2 | |
Pravastatin, another HMG-CoA reductase inhibitor, can indirectly enhance NSDHL activity by increasing the demand for cholesterol biosynthesis. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin inhibits HMG-CoA reductase, indirectly enhancing NSDHL activity by increasing the need for cholesterol biosynthesis. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Rosuvastatin inhibits HMG-CoA reductase, indirectly enhancing NSDHL activity by increasing the need for cholesterol biosynthesis. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin is a HMG-CoA reductase inhibitor that can indirectly enhance NSDHL activity by increasing the demand for cholesterol biosynthesis. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
Mevastatin inhibits HMG-CoA reductase, and thereby can indirectly enhance NSDHL activity via the same mechanism as the other statins. | ||||||